These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36759861)

  • 1. The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome, RNA and inflammation.
    Reinhold D; Farztdinov V; Yan Y; Meisel C; Sadlowski H; Kühn J; Perschel FH; Endres M; Düzel E; Vielhaber S; Guttek K; Goihl A; Venø M; Teegen B; Stöcker W; Stubbemann P; Kurth F; Sander LE; Ralser M; Otto C; Streit S; Jarius S; Ruprecht K; Radbruch H; Kjems J; Mülleder M; Heppner F; Körtvelyessy P
    J Neuroinflammation; 2023 Feb; 20(1):30. PubMed ID: 36759861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.
    Jarius S; Pache F; Körtvelyessy P; Jelčić I; Stettner M; Franciotta D; Keller E; Neumann B; Ringelstein M; Senel M; Regeniter A; Kalantzis R; Willms JF; Berthele A; Busch M; Capobianco M; Eisele A; Reichen I; Dersch R; Rauer S; Sandner K; Ayzenberg I; Gross CC; Hegen H; Khalil M; Kleiter I; Lenhard T; Haas J; Aktas O; Angstwurm K; Kleinschnitz C; Lewerenz J; Tumani H; Paul F; Stangel M; Ruprecht K; Wildemann B;
    J Neuroinflammation; 2022 Jan; 19(1):19. PubMed ID: 35057809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-Generation Sequencing and Proteomics of Cerebrospinal Fluid From COVID-19 Patients With Neurological Manifestations.
    Wang H; Zhang Z; Zhou J; Han S; Kang Z; Chuang H; Fan H; Zhao H; Wang L; Ning Y; Sarapultsev A; Li WX; Li J; Lin Z; Luo S; Xiong N; Hu D
    Front Immunol; 2021; 12():782731. PubMed ID: 34956212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm.
    Garcia MA; Barreras PV; Lewis A; Pinilla G; Sokoll LJ; Kickler T; Mostafa H; Caturegli M; Moghekar A; Fitzgerald KC; ; Pardo CA
    J Neurol Sci; 2021 Aug; 427():117517. PubMed ID: 34090021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted metabolomics identifies accurate CSF metabolite biomarkers for the differentiation between COVID-19 with neurological involvement and CNS infections with neurotropic viral pathogens.
    Neu F; Nay S; Schuchardt S; Klawonn F; Skripuletz T; Suehs KW; Pessler F
    J Transl Med; 2024 Jul; 22(1):620. PubMed ID: 38961383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 and autoantibodies in the cerebrospinal fluid of COVID-19 patients: prospective multicentre cohort study.
    Nersesjan V; Amiri M; Nilsson AC; Wamberg C; Jensen VVS; Petersen CB; Hejl AM; Lebech AM; Theut AM; Jørgensen CS; Blaabjerg M; Benros ME; Kondziella D
    Brain Commun; 2023; 5(5):fcad274. PubMed ID: 37908236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development.
    Espíndola OM; Brandão CO; Gomes YCP; Siqueira M; Soares CN; Lima MASD; Leite ACCB; Torezani G; Araujo AQC; Silva MTT
    Int J Infect Dis; 2021 Jan; 102():155-162. PubMed ID: 33127503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal inflammatory responses in the absence of SARS-CoV-2 nucleic acid in the CSF of COVID-19 hospitalized patients.
    Normandin E; Holroyd KB; Collens SI; Shaw BM; Siddle KJ; Adams G; Rudy M; Solomon IH; Anahtar MN; Lemieux JE; Trombetta BA; Kivisakk P; Arnold SE; Rapalino O; Piantadosi AL; Sen P; Rosenberg ES; Branda J; Sabeti PC; Mukerji SS
    J Neurol Sci; 2021 Nov; 430():120023. PubMed ID: 34678659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms.
    Edén A; Grahn A; Bremell D; Aghvanyan A; Bathala P; Fuchs D; Gostner J; Hagberg L; Kanberg N; Kanjananimmanont S; Lindh M; Misaghian S; Nilsson S; Schöll M; Sigal G; Stentoft E; Studahl M; Yilmaz A; Wang M; Stengelin M; Zetterberg H; Gisslén M
    JAMA Netw Open; 2022 May; 5(5):e2213253. PubMed ID: 35604688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL11 production in cerebrospinal fluid distinguishes herpes simplex meningitis from herpes simplex encephalitis.
    Lind L; Studahl M; Persson Berg L; Eriksson K
    J Neuroinflammation; 2017 Jul; 14(1):134. PubMed ID: 28693588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal Fluid Protein Markers Indicate Neuro-Damage in SARS-CoV-2-Infected Nonhuman Primates.
    Maity S; Mayer MG; Shu Q; Linh H; Bao D; Blair RV; He Y; Lyon CJ; Hu TY; Fischer T; Fan J
    Mol Cell Proteomics; 2023 Apr; 22(4):100523. PubMed ID: 36870567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.
    Virhammar J; Nääs A; Fällmar D; Cunningham JL; Klang A; Ashton NJ; Jackmann S; Westman G; Frithiof R; Blennow K; Zetterberg H; Kumlien E; Rostami E
    Eur J Neurol; 2021 Oct; 28(10):3324-3331. PubMed ID: 33369818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid in COVID-19 neurological complications: no cytokine storm or neuroinflammation.
    Garcia MA; Barreras PV; Lewis A; Pinilla G; Sokoll LJ; Kickler T; Mostafa H; Caturegli M; Moghekar A; Fitzgerald KC; Pardo CA
    medRxiv; 2021 Jan; ():. PubMed ID: 33469596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults.
    Sköldenberg B; Aurelius E; Hjalmarsson A; Sabri F; Forsgren M; Andersson B; Linde A; Strannegård O; Studahl M; Hagberg L; Rosengren L
    J Neurol; 2006 Feb; 253(2):163-70. PubMed ID: 16222428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid cyto-/chemokine profile during acute herpes simplex virus induced anti-N-methyl-d-aspartate receptor encephalitis and in chronic neurological sequelae.
    Kothur K; Gill D; Wong M; Mohammad SS; Bandodkar S; Arbunckle S; Wienholt L; Dale RC
    Dev Med Child Neurol; 2017 Aug; 59(8):806-814. PubMed ID: 28439892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of COVID-19-related encephalitis: comparison with the features of herpes virus encephalitis and autoimmune encephalitis.
    Cui Y; Chen Z; Kong Y; Wang Y; Wang Y; Zhang J; Wang L; Zhang J; Sun W; Wu L
    Neurol Sci; 2024 Aug; 45(8):3573-3582. PubMed ID: 38772979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study on viral CNS inflammation beyond herpes encephalitis.
    Jordan B; Kösling S; Emmer A; Koch A; Müller T; Kornhuber M
    J Neurovirol; 2016 Dec; 22(6):763-773. PubMed ID: 27173398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated cerebrospinal fluid IgG index in herpes simplex encephalitis post-HSV-1 clearance: A preliminary study.
    Asakura M; Mizutani Y; Shima S; Kawamura Y; Ueda A; Ito M; Mutoh T; Yoshikawa T; Watanabe H
    J Med Virol; 2024 Aug; 96(8):e29850. PubMed ID: 39119996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.